BRPI1012890A2 - composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kit - Google Patents
composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kitInfo
- Publication number
- BRPI1012890A2 BRPI1012890A2 BRPI1012890A BRPI1012890A BRPI1012890A2 BR PI1012890 A2 BRPI1012890 A2 BR PI1012890A2 BR PI1012890 A BRPI1012890 A BR PI1012890A BR PI1012890 A BRPI1012890 A BR PI1012890A BR PI1012890 A2 BRPI1012890 A2 BR PI1012890A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- immunogenic composition
- kit
- preparing
- aqueous adjuvant
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 2
- 239000002671 adjuvant Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0910046.2 | 2009-06-10 | ||
GBGB0910046.2A GB0910046D0 (en) | 2009-06-10 | 2009-06-10 | Novel compositions |
PCT/EP2010/058017 WO2010142685A1 (en) | 2009-06-10 | 2010-06-08 | Adjuvant compositions comprising a non-ionic isotonicity agent |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI1012890A2 true BRPI1012890A2 (pt) | 2018-02-27 |
BRPI1012890B1 BRPI1012890B1 (pt) | 2022-03-22 |
Family
ID=40937237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1012890-5A BRPI1012890B1 (pt) | 2009-06-10 | 2010-06-08 | Composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kit |
Country Status (31)
Country | Link |
---|---|
US (2) | US20120087976A1 (pt) |
EP (1) | EP2440242B1 (pt) |
JP (3) | JP5647677B2 (pt) |
KR (1) | KR101473686B1 (pt) |
CN (2) | CN104367997B (pt) |
AU (1) | AU2010257538B2 (pt) |
BR (1) | BRPI1012890B1 (pt) |
CA (1) | CA2764421C (pt) |
CL (1) | CL2011003113A1 (pt) |
CO (1) | CO6440528A2 (pt) |
CY (1) | CY1115522T1 (pt) |
DK (1) | DK2440242T3 (pt) |
DO (1) | DOP2011000346A (pt) |
EA (1) | EA024074B1 (pt) |
ES (1) | ES2494442T3 (pt) |
GB (1) | GB0910046D0 (pt) |
HR (1) | HRP20140792T1 (pt) |
IL (1) | IL216231A0 (pt) |
MA (1) | MA33412B1 (pt) |
MX (1) | MX2011013162A (pt) |
MY (1) | MY159819A (pt) |
NZ (1) | NZ596503A (pt) |
PE (1) | PE20120319A1 (pt) |
PL (1) | PL2440242T3 (pt) |
PT (1) | PT2440242E (pt) |
RS (1) | RS53550B1 (pt) |
SG (1) | SG176638A1 (pt) |
SI (1) | SI2440242T1 (pt) |
SM (1) | SMT201400134B (pt) |
UA (1) | UA104888C2 (pt) |
WO (1) | WO2010142685A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE028278T2 (en) | 2009-06-10 | 2016-12-28 | Chugai Pharmaceutical Co Ltd | Tetracyclic compound |
SG187614A1 (en) | 2010-08-20 | 2013-03-28 | Chugai Pharmaceutical Co Ltd | Composition containing tetracyclic compound |
SG190937A1 (en) * | 2010-12-14 | 2013-07-31 | Glaxosmithkline Biolog Sa | Mycobacterium antigenic composition |
PL2902029T3 (pl) | 2012-09-25 | 2019-01-31 | Chugai Seiyaku Kabushiki Kaisha | Inhibitor RET |
US10434167B2 (en) * | 2014-03-25 | 2019-10-08 | The Government Of The United States As Represented By The Secretary Of The Army | Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin |
CN106458967A (zh) | 2014-04-25 | 2017-02-22 | 中外制药株式会社 | 四环化合物的新结晶 |
CA3140565C (en) | 2014-04-25 | 2022-10-11 | Chugai Seiyaku Kabushiki Kaisha | Preparation containing tetracyclic compound at high dose |
TWI831347B (zh) | 2014-08-08 | 2024-02-01 | 日商中外製藥股份有限公司 | 包含4環性化合物的非晶質體之固體分散體及製劑 |
MX2017009246A (es) | 2015-01-16 | 2017-10-12 | Chugai Pharmaceutical Co Ltd | Farmaco de combinacion. |
WO2017079582A1 (en) | 2015-11-06 | 2017-05-11 | Adjuvance Technologies, Inc. | Triterpene saponin analogues |
MX2019006728A (es) * | 2016-12-07 | 2019-12-02 | Glaxosmithkline Biologicals Sa | Nuevo proceso. |
CA3075822A1 (en) | 2017-10-16 | 2019-04-25 | Adjuvance Technologies, Inc. | Triterpene saponin analogues |
BR112020010790A2 (pt) | 2017-12-01 | 2020-11-10 | Glaxosmithkline Biologicals S.A. | purificação da saponina |
CN111372604A (zh) | 2017-12-01 | 2020-07-03 | 葛兰素史密丝克莱恩生物有限公司 | 皂苷提取 |
KR102635225B1 (ko) | 2018-09-04 | 2024-02-07 | 추가이 세이야쿠 가부시키가이샤 | 4환성 화합물의 제조방법 |
EP3886901A1 (en) * | 2018-11-29 | 2021-10-06 | GlaxoSmithKline Biologicals S.A. | Methods for manufacturing an adjuvant |
WO2024190865A1 (ja) * | 2023-03-15 | 2024-09-19 | ユナイテッド・イミュニティ株式会社 | 脂質粒子 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804381A (en) | 1996-10-03 | 1998-09-08 | Cornell Research Foundation | Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
PT812593E (pt) * | 1993-03-23 | 2002-01-30 | Smithkline Beecham Biolog | Vacinas contendo monofosforil-lipido a 3-o-desacilado na sua composicao |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
DE19803453A1 (de) * | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
IL137442A0 (en) | 1998-02-05 | 2001-07-24 | Smithkline Beecham Biolog | Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
PT1075276E (pt) * | 1998-05-07 | 2008-01-22 | Corixa Corp | Composição adjuvante e métodos para sua utilização |
JP3765232B2 (ja) | 2000-11-16 | 2006-04-12 | 株式会社ジェイテクト | 電動式パワーステアリング装置及びこれに用いる歯車の製造方法 |
GB0409940D0 (en) | 2004-05-04 | 2004-06-09 | Glaxosmithkline Biolog Sa | Vaccine |
GB0411411D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxosmithkline Biolog Sa | Vaccines |
JP2008521385A (ja) * | 2004-11-29 | 2008-06-26 | 長春華普生物技術有限公司 | アジュバントとしてのCpG含有一本鎖デオキシヌクレオチド |
ATE462444T1 (de) * | 2005-06-27 | 2010-04-15 | Glaxosmithkline Biolog Sa | Immunogene zusammensetzung |
TWI457133B (zh) * | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
ES2398492T3 (es) | 2007-01-15 | 2013-03-19 | Glaxosmithkline Biologicals Sa | Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1 |
JP5391080B2 (ja) | 2007-01-15 | 2014-01-15 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
CA2687632C (en) * | 2007-05-24 | 2013-01-15 | Glaxosmithkline Biologicals S.A. | Lyophilised antigen composition |
GB0910045D0 (en) * | 2009-06-10 | 2009-07-22 | Glaxosmithkline Biolog Sa | Novel compositions |
-
2009
- 2009-06-10 GB GBGB0910046.2A patent/GB0910046D0/en not_active Ceased
-
2010
- 2010-06-08 WO PCT/EP2010/058017 patent/WO2010142685A1/en active Application Filing
- 2010-06-08 CN CN201410497386.1A patent/CN104367997B/zh active Active
- 2010-06-08 PE PE2011002071A patent/PE20120319A1/es not_active Application Discontinuation
- 2010-06-08 MA MA34506A patent/MA33412B1/fr unknown
- 2010-06-08 EA EA201190286A patent/EA024074B1/ru not_active IP Right Cessation
- 2010-06-08 SI SI201030689T patent/SI2440242T1/sl unknown
- 2010-06-08 DK DK10721036.1T patent/DK2440242T3/da active
- 2010-06-08 CA CA2764421A patent/CA2764421C/en active Active
- 2010-06-08 CN CN201080024992.1A patent/CN102458457B/zh active Active
- 2010-06-08 MX MX2011013162A patent/MX2011013162A/es active IP Right Grant
- 2010-06-08 PL PL10721036T patent/PL2440242T3/pl unknown
- 2010-06-08 KR KR1020127000650A patent/KR101473686B1/ko active IP Right Grant
- 2010-06-08 UA UAA201113798A patent/UA104888C2/uk unknown
- 2010-06-08 AU AU2010257538A patent/AU2010257538B2/en active Active
- 2010-06-08 RS RSP20140476 patent/RS53550B1/en unknown
- 2010-06-08 EP EP10721036.1A patent/EP2440242B1/en active Active
- 2010-06-08 JP JP2012514447A patent/JP5647677B2/ja active Active
- 2010-06-08 SG SG2011089315A patent/SG176638A1/en unknown
- 2010-06-08 MY MYPI2011005958A patent/MY159819A/en unknown
- 2010-06-08 NZ NZ596503A patent/NZ596503A/xx not_active IP Right Cessation
- 2010-06-08 BR BRPI1012890-5A patent/BRPI1012890B1/pt active IP Right Grant
- 2010-06-08 PT PT107210361T patent/PT2440242E/pt unknown
- 2010-06-08 ES ES10721036.1T patent/ES2494442T3/es active Active
- 2010-06-08 US US13/377,425 patent/US20120087976A1/en not_active Abandoned
-
2011
- 2011-11-09 IL IL216231A patent/IL216231A0/en active IP Right Grant
- 2011-11-11 DO DO2011000346A patent/DOP2011000346A/es unknown
- 2011-12-07 CL CL2011003113A patent/CL2011003113A1/es unknown
- 2011-12-12 CO CO11170871A patent/CO6440528A2/es active IP Right Grant
-
2014
- 2014-08-20 HR HRP20140792AT patent/HRP20140792T1/hr unknown
- 2014-08-29 CY CY20141100698T patent/CY1115522T1/el unknown
- 2014-09-15 SM SM201400134T patent/SMT201400134B/xx unknown
- 2014-09-26 JP JP2014196018A patent/JP5977789B2/ja active Active
-
2016
- 2016-05-16 JP JP2016097525A patent/JP6261647B2/ja active Active
-
2017
- 2017-07-10 US US15/645,473 patent/US20180021417A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1012890A2 (pt) | composição adjuvante aquosa, composição imunogênica, processo para preparar uma composição imunogênica, e, kit | |
BRPI0916884A2 (pt) | composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit | |
BR112013014598A2 (pt) | composição imunogênica, uso de uma composição imunogênica, processo para preparar uma composição imunogênica, método para a fabricação de uma composição imunogênica estável, e, kit | |
BRPI1010775A2 (pt) | composição, método para preparar uma composição, e, uso de uma composição. | |
BRPI0909820A2 (pt) | Processo para estabilização de composição de vacina contra gripe, para estabilização de composição de vacina contendo adjuvante e para preparação de vacina, composições de vacina, kit de vacina e método de estocagem de uma matéria prima | |
BRPI1006141A2 (pt) | composições de anticorpo modificado, métodos para preparar e usar as mesmas | |
BRPI0918349A2 (pt) | Processo para preparar dióxido de divinilareno | |
BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
BRPI0813307A2 (pt) | Composição imunogênica, vacina, e, processo para fabricar a vacina | |
BR112012004807A2 (pt) | vacina para pcsk9 | |
BRPI0924622A2 (pt) | composições para tratamento de tecidos, processo de fabricação, e método de uso. | |
BRPI0919192A2 (pt) | Uso de lipídio, composição nutricional, e, processo para a produção de uma composição nutricional | |
BRPI1014606A2 (pt) | Maltotriosil transferase, processo para produção e uso da mesma | |
BRPI1013561A8 (pt) | processo para a preparação de alogliptina | |
BRPI0921399A2 (pt) | composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante | |
BRPI0911815A2 (pt) | estrutura de multifilme, estrutura de envelope feita de uma estrutura de multifilme, uso de uma estrutura de multifilme e processo para preparar uma estrutura de multifilme | |
BRPI0922984A2 (pt) | processo para preparar trietanolamina pura | |
BRPI1005919A2 (pt) | composição imunogênica | |
BRPI1011639A2 (pt) | composição anticongelante, e, método para aumentar a estabilidade térmica de uma composição anticongelante | |
BRPI1008484A2 (pt) | codificador, decodificador e método para os mesmos | |
BRPI1010617A2 (pt) | uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição. | |
BRPI1013051A2 (pt) | composição imunogênica, uso de uma composição imunogênica, processo para fazer uma composição imunogênica, e, kit. | |
BR112012001998A2 (pt) | solução oftálmica, uso de um composto, e, método para preparação de uma solução oftálmica. | |
BR112012008202A2 (pt) | processo de preparação de uma composição, componentes e uso da composição | |
BR112013012873A2 (pt) | processo para preparar uma n, n-dialquiletanolamina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/06/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |